Two Sigma Advisers’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-581,600
| Closed | -$10.5M | – | 2742 |
|
|
2020
Q2 | $10.5M | Sell |
581,600
-174,200
| -23% | -$3.13M | 0.03% | 533 |
|
|
2020
Q1 | $5.39M | Buy |
755,800
+396,100
| +110% | +$2.82M | 0.02% | 686 |
|
|
2019
Q4 | $8.59M | Buy |
359,700
+11,900
| +3% | +$284K | 0.02% | 640 |
|
|
2019
Q3 | $9.33M | Buy |
347,800
+111,700
| +47% | +$3M | 0.02% | 563 |
|
|
2019
Q2 | $6.41M | Buy |
+236,100
| New | +$6.41M | 0.02% | 734 |
|
|
2018
Q2 | – | Sell |
-23,800
| Closed | -$777K | – | 2557 |
|
|
2018
Q1 | $777K | Sell |
23,800
-331,900
| -93% | -$10.8M | ﹤0.01% | 1650 |
|
|
2017
Q4 | $17.3M | Buy |
355,700
+162,800
| +84% | +$7.92M | 0.05% | 441 |
|
|
2017
Q3 | $10.4M | Buy |
192,900
+39,509
| +26% | +$2.13M | 0.03% | 550 |
|
|
2017
Q2 | $8.62M | Buy |
153,391
+139,655
| +1,017% | +$7.84M | 0.03% | 554 |
|
|
2017
Q1 | $538K | Buy |
+13,736
| New | +$538K | ﹤0.01% | 1860 |
|
|
2016
Q3 | – | Sell |
-58,500
| Closed | -$1.38M | – | 2358 |
|
|
2016
Q2 | $1.38M | Buy |
58,500
+5,500
| +10% | +$130K | 0.01% | 1016 |
|
|
2016
Q1 | $1.08M | Buy |
53,000
+39,900
| +305% | +$814K | 0.01% | 1085 |
|
|
2015
Q4 | $674K | Buy |
13,100
+5,400
| +70% | +$278K | ﹤0.01% | 1210 |
|
|
2015
Q3 | $328K | Sell |
7,700
-3,300
| -30% | -$141K | ﹤0.01% | 1458 |
|
|
2015
Q2 | $501K | Sell |
11,000
-35,400
| -76% | -$1.61M | ﹤0.01% | 1420 |
|
|
2015
Q1 | $1.76M | Buy |
46,400
+36,400
| +364% | +$1.38M | 0.01% | 829 |
|
|
2014
Q4 | $283K | Buy |
+10,000
| New | +$283K | ﹤0.01% | 1721 |
|